Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Xin Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4972-7561; OpenAlex author ID A5100779371. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6. Co-author DOI 10.1016/j.pan.2023.06.011↗
  2. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Co-author DOI 10.1007/s13105-020-00734-4↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Liu · 1 shared paper, 2023 · strength 0.26
  2. Yao Wang · 1 shared paper, 2023 · strength 0.26
  3. Baosheng Wang · 1 shared paper, 2020 · strength 0.15
  4. Zhen Liu · 1 shared paper, 2020 · strength 0.15
  5. Xiangpeng Meng · 1 shared paper, 2020 · strength 0.15
  6. Jia Ma · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.